Venture Capital

Inmagene Biopharmaceuticals Closed $21 Million Series B Financing, Making The Total Raised To Date Over $40M

by prnewswire.com posted 7months ago 395 views
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors. The Series B financing...